title: Tungstic acid reduction of cold-resistant stress-induced ulceration in rats.
abstract: Sprague-Dawley rats were restrained at 4 degrees C for 2 h (stress). Tungstic acid in a single dose of 0.01, 0.1, 1, 10, 100 or 300 mg/kg (dissolved in distilled water) was administered intragastrically to animals 30 min prior to stress. Stress induced significant gastric mucosal damage, whereas tungstic acid pretreatment dose-dependently reduced lesion formation. Doses of tungstic acid of 1 mg/kg and higher significantly (P < 0.05-0.001) decreased ulcers. The mucosal mast cell counts in rats pretreated with tungstic acid were significantly higher than those of control rats. In motility experiments using oral administration of amberlite pellets, pretreatment with tungstic acid dose-dependently reduced the gastric emptying rate during a 1 h period of stress. Gastric mucosal xanthine oxidase and superoxide dismutase (SOD) activities, after pretreatment with a single dose of tungstic acid, were not altered in stressed animals. It is suggested that tungstic acid effectively antagonizes stress-induced gastric ulcers, possibly by decreasing motility and mass cell degranulation. Xanthine oxidase and SOD activities and mucous content were not changed in the gastric mucosa by the present method of tungstic acid administration.
authors.affiliation: Department of Medicine, Shantou University Medical College, People's Republic of China.
authors.forename: B S
authors.initials: BS
authors.lastname: Qiu
authors.forename: C J
authors.initials: CJ
authors.lastname: Pfeiffer
authors.forename: W
authors.initials: W
authors.lastname: Wu
authors.forename: C H
authors.initials: CH
authors.lastname: Cho
mesh_terms: D000818:Animals; D015550:Cell Degranulation; D003080:Cold Temperature / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D005746:Gastric Emptying / Q000187:drug effects; D005753:Gastric Mucosa / Q000201:enzymology / Q000473:pathology; D008407:Mast Cells / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013276:Stomach Ulcer / Q000517:prevention & control*; D013312:Stress, Physiological / Q000150:complications*; D013482:Superoxide Dismutase / Q000378:metabolism; D017973:Tungsten Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D014969:Xanthine Oxidase / Q000378:metabolism
chemical_list: D017973:Tungsten Compounds; D013482:Superoxide Dismutase; D014969:Xanthine Oxidase; C021101:tungstic(VI) acid